New treatments for severe treatment-resistant asthma: targeting the right patient.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  The Lancet Respiratory Medicine

• Publication date

  2013-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S2213-2600(13)70128-0PMID 24461667
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Azithromycin for prevention of exacerbations in severe asthma (AZISAST): a multicentre randomised double-blind placebo-controlled trial

  2013cited by this paper
• Safety and efficacy of the prostaglandin D2 receptor antagonist AMG 853 in asthmatic patients.

  2013cited by this paper
• Dupilumab in persistent asthma with elevated eosinophil levels.

  2013cited by this paper
• A proof-of-concept, randomized, controlled trial of omalizumab in patients with severe, difficult-to-control, nonatopic asthma.

  2013cited by this paper
• Sputum hydrogen sulfide as a novel biomarker of obstructive neutrophilic asthma.

  2013cited by this paper
• Golimumab for the Treatment of Rheumatoid Arthritis After the Failure of Previous Disease-Modifying Antirheumatic Drugs: A NICE Single Technology Appraisal

  2013cited by this paper
• Application of ’omics technologies to biomarker discovery in inflammatory lung diseases

  2013cited by this paper
• Exploring the effects of omalizumab in allergic asthma: an analysis of biomarkers in the EXTRA study.

  2013cited by this paper
• How variability in clinical phenotypes should guide research into disease mechanisms in asthma.

  2013cited by this paper
• Targeting interleukin-4 in asthma: lost in translation?

  2012cited by this paper
• Reduction of total IgE by targeted coengagement of IgE B-cell receptor and FcγRIIb with Fc-engineered antibody.

  2012cited by this paper
• Effects of Adding Omalizumab, an Anti-Immunoglobulin E Antibody, on Airway Wall Thickening in Asthma

  2012cited by this paper
• Thymic Stromal Lymphopoietin: A Promising Therapeutic Target for Allergic Diseases

  2012cited by this paper
• The investigation of severe asthma to define phenotypes

  2012cited by this paper
• Pediatric severe asthma is characterized by eosinophilia and remodeling without T(H)2 cytokines.

  2012cited by this paper
• Increased expression of immunoreactive thymic stromal lymphopoietin in patients with severe asthma.

  2012cited by this paper
• Personal omics profiling reveals dynamic molecular and medical phenotypes.

  2012cited by this paper
• Omalizumab Modulates Bronchial Reticular Basement Membrane Thickness and Eosinophil Infiltration in Severe Persistent Allergic Asthma Patients

  2012cited by this paper
• Asthma outcomes: biomarkers.

  2012cited by this paper
• A randomized, double‐blind, placebo‐controlled study of the CRTH2 antagonist OC000459 in moderate persistent asthma

  2012cited by this paper
• Tiotropium in asthma poorly controlled with standard combination therapy.

  2012cited by this paper
• From "blockbusters" to "biosimilars": an opportunity for patients, medical specialists and health care providers.

  2012cited by this paper
• Asthma phenotypes: the evolution from clinical to molecular approaches

  2012cited by this paper
• New approaches to personalized medicine for asthma: where are we?

  2012cited by this paper
• Inflammatory biomarkers in severe asthma

  2012cited by this paper
• A phase II placebo-controlled study of tralokinumab in moderate-to-severe asthma

  2012cited by this paper
• An anti-IgE monoclonal antibody that binds to IgE on CD23 but not on high-affinity IgE.Fc receptors.

  2012cited by this paper
• Epigenetics in asthma and COPD.

  2012cited by this paper
• An Official ATS Clinical Practice Guideline: Interpretation of Exhaled Nitric Oxide Levels (FeNO) for Clinical Applications

  2012cited by this paper
• A large subgroup of mild-to-moderate asthma is persistently noneosinophilic.

  2012cited by this paper
• Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial.

  2012cited by this paper
• Corticosteroid insensitivity of chemokine expression in airway smooth muscle of patients with severe asthma.

  2012cited by this paper
• Bacteria in sputum of stable severe asthma and increased airway wall thickness

  2012cited by this paper
• Safety and efficacy of a CXCR2 antagonist in patients with severe asthma and sputum neutrophils: a randomized, placebo‐controlled clinical trial

  2012cited by this paper
• Cluster Analysis of Obesity and Asthma Phenotypes

  2012cited by this paper
• Software for systems biology: from tools to integrated platforms

  2011cited by this paper
• Randomized trial of omalizumab (anti-IgE) for asthma in inner-city children.

  2011cited by this paper
• Transcriptional phenotypes of asthma defined by gene expression profiling of induced sputum samples.

  2011cited by this paper
• Periostin is a systemic biomarker of eosinophilic airway inflammation in asthmatic patients.

  2011cited by this paper
• Reslizumab for poorly controlled, eosinophilic asthma: a randomized, placebo-controlled study.

  2011cited by this paper
• An official ATS clinical practice guideline: interpretation of exhaled nitric oxide levels (FENO) for clinical applications.

  2011cited by this paper
• Use of sputum eosinophil counts to guide management in children with severe asthma

  2011cited by this paper
• Lebrikizumab treatment in adults with asthma.

  2011cited by this paper
• Omalizumab in Severe Allergic Asthma Inadequately Controlled With Standard Therapy

  2011cited by this paper
• Asthma endotypes: a new approach to classification of disease entities within the asthma syndrome.

  2011cited by this paper
• Safety profile and clinical activity of multiple subcutaneous doses of MEDI-528, a humanized anti-interleukin-9 monoclonal antibody, in two randomized phase 2a studies in subjects with asthma

  2011cited by this paper
• Tiotropium Bromide Step-Up Therapy for Adults with Uncontrolled Asthma

  2011cited by this paper
• Heterogeneity of severe asthma in childhood: confirmation by cluster analysis of children in the National Institutes of Health/National Heart, Lung, and Blood Institute Severe Asthma Research Program.

  2011cited by this paper
• Corticosteroids: use and insensitivity in severe asthma

  2011cited by this paper
• Airway microbiota and bronchial hyperresponsiveness in patients with suboptimally controlled asthma.

  2011cited by this paper
• Tiotropium improves lung function in patients with severe uncontrolled asthma: a randomized controlled trial.

  2011cited by this paper
• Analyses of asthma severity phenotypes and inflammatory proteins in subjects stratified by sputum granulocytes.

  2010cited by this paper
• Effectiveness and safety of bronchial thermoplasty in the treatment of severe asthma: a multicenter, randomized, double-blind, sham-controlled clinical trial.

  2010cited by this paper
• Molecular mechanisms of oxidative stress in airways and lungs with reference to asthma and chronic obstructive pulmonary disease

  2010cited by this paper
• Safety profile, pharmacokinetics, and biologic activity of MEDI-563, an anti-IL-5 receptor alpha antibody, in a phase I study of subjects with mild asthma.

  2010cited by this paper
• Addition of long-acting beta2-agonists to inhaled corticosteroids versus same dose inhaled corticosteroids for chronic asthma in adults and children.

  2010cited by this paper
• Identification of asthma phenotypes using cluster analysis in the Severe Asthma Research Program.

  2010cited by this paper
• Increased IL-33 expression by epithelial cells in bronchial asthma.

  2010cited by this paper
• Tiotropium bromide step-up therapy for adults with uncontrolled asthma.

  2010cited by this paper
• Disordered Microbial Communities in Asthmatic Airways

  2010cited by this paper
• An integrative systems biology approach to understanding pulmonary diseases.

  2010cited by this paper
• Potentially pathogenic bacteria cultured from the sputum of stable asthmatics are associated with increased 8-isoprostane and airway neutrophilia

  2010cited by this paper
• The path to personalized medicine.

  2010cited by this paper
• Use of exhaled nitric oxide measurement to identify a reactive, at-risk phenotype among patients with asthma.

  2010cited by this paper
• A randomized, controlled, phase 2 study of AMG 317, an IL-4Ralpha antagonist, in patients with asthma.

  2010cited by this paper
• A trial of clarithromycin for the treatment of suboptimally controlled asthma.

  2010cited by this paper
• Narrative Review: The Role of Th2 Immune Pathway Modulation in the Treatment of Severe Asthma and Its Phenotypes

  2010cited by this paper
• A randomized, double-blind, placebo-controlled study of tumor necrosis factor-alpha blockade in severe persistent asthma.

  2009cited by this paper
• Mepolizumab for prednisone-dependent asthma with sputum eosinophilia.

  2009cited by this paper
• A multivariate analysis of risk factors for the air-trapping asthmatic phenotype as measured by quantitative CT analysis.

  2009cited by this paper
• CXCR2 antagonists for the treatment of pulmonary disease.

  2009cited by this paper
• T-helper type 2-driven inflammation defines major subphenotypes of asthma.

  2009cited by this paper
• SCH527123, a novel CXCR2 antagonist, inhibits ozone-induced neutrophilia in healthy subjects

  2009cited by this paper
• Mepolizumab and exacerbations of refractory eosinophilic asthma.

  2009cited by this paper
• Effect of p38 MAPK inhibition on corticosteroid suppression of cytokine release in severe asthma

  2009cited by this paper
• An official American Thoracic Society/European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice.

  2009cited by this paper
• Inhaled corticosteroids as combination therapy with β-adrenergic agonists in airways disease: present and future

  2009cited by this paper
• Masitinib, a c‐kit/PDGF receptor tyrosine kinase inhibitor, improves disease control in severe corticosteroid‐dependent asthmatics

  2009cited by this paper
• Inflammatory biomarkers in airways of patients with severe asthma compared with non‐severe asthma

  2009cited by this paper
• T(H)17-associated cytokines (IL-17A and IL-17F) in severe asthma.

  2009cited by this paper
• Relative corticosteroid insensitivity of alveolar macrophages in severe asthma compared with non-severe asthma

  2008cited by this paper
• Lung function in adults with stable but severe asthma: air trapping and incomplete reversal of obstruction with bronchodilation.

  2008cited by this paper
• Azithromycin or montelukast as inhaled corticosteroid-sparing agents in moderate-to-severe childhood asthma study.

  2008cited by this paper
• Airway remodeling measured by multidetector CT is increased in severe asthma and correlates with pathology.

  2008cited by this paper
• TH17 Cells Mediate Steroid-Resistant Airway Inflammation and Airway Hyperresponsiveness in Mice1

  2008cited by this paper
• Daclizumab improves asthma control in patients with moderate to severe persistent asthma: a randomized, controlled trial.

  2008cited by this paper
• Endotyping asthma: new insights into key pathogenic mechanisms in a complex, heterogeneous disease.

  2008cited by this paper
• Body mass and glucocorticoid response in asthma.

  2008cited by this paper
• Cluster analysis and clinical asthma phenotypes.

  2008cited by this paper
• Alveolar macrophage phagocytosis is impaired in children with poorly controlled asthma.

  2008cited by this paper
• Clarithromycin targets neutrophilic airway inflammation in refractory asthma.

  2008cited by this paper
• Antagonism of the prostaglandin D2 receptors DP1 and CRTH2 as an approach to treat allergic diseases

  2007cited by this paper
• Safety and efficacy of bronchial thermoplasty in symptomatic, severe asthma.

  2007cited by this paper
• Airway smooth muscle dynamics: a common pathway of airway obstruction in asthma.

  2007cited by this paper
• Characterization of the severe asthma phenotype by the National Heart, Lung, and Blood Institute's Severe Asthma Research Program.

  2007cited by this paper
• Genome-wide profiling identifies epithelial cell genes associated with asthma and with treatment response to corticosteroids

  2007cited by this paper
• A study to evaluate safety and efficacy of mepolizumab in patients with moderate persistent asthma.

  2007cited by this paper
• Effect of an interleukin-4 variant on late phase asthmatic response to allergen challenge in asthmatic patients: results of two phase 2a studies.

  2007cited by this paper
• IL‐33 is a chemoattractant for human Th2 cells

  2007cited by this paper
• Anti-IgE for chronic asthma in adults and children.

  2006cited by this paper

• Role of precision medicine on different endotypes of asthma

  2025cites this paper
• Molecular Study from the Signaling Pathways of Four Potential asthma triggers: AKT1, MAPK13, STAT1, and TLR4

  2025cites this paper
• Evaluating the Influence of CHI3L1 and PI3 Methylation in Allergic and Nonallergic Asthma

  2025cites this paper
• The role of mitochondria in eosinophil function: implications for severe asthma pathogenesis

  2024cites this paper
• CD11c+ dendritic cells PlexinD1 deficiency exacerbates airway hyperresponsiveness, IgE and mucus production in a mouse model of allergic asthma

  2024cites this paper
• Gene signatures in U-BIOPRED severe asthma for molecular phenotyping and precision medicine: time for clinical use

  2023cites this paper
• PlexinD1 deficiency in CD11c+ dendritic cells exacerbates airway hyperresponsiveness and enhances IgE and mucus production in allergic asthma

  2023cites this paper
• Integrated Mechanisms of Polarity–Based Extracts of Cucumis melo L. Seed Kernels for Airway Smooth Muscle Relaxation via Key Signaling Pathways Based on WGCNA, In Vivo, and In Vitro Analyses

  2022cites this paper
• Selective Pharmaceutical Inhibition of PARP14 Mitigates Allergen-Induced IgE and Mucus Overproduction in a Mouse Model of Pulmonary Allergic Response

  2022cites this paper
• Associations of the Methylation Levels of NFAT5, PVT1, RPS6KA1, and MIB1 with Steroid-Resistant Asthma

  2022cites this paper
• Characteristics, phenotypes, mechanisms and management of severe asthma

  2022cites this paper
• Human Lung Mast Cells Impair Corticosteroid Responsiveness in Human Airway Smooth Muscle Cells

  2021cites this paper
• Potential Role of Mast Cells in Regulating Corticosteroid Insensitivity in Severe Asthma.

  2021cites this paper
• The Pathogenesis of Eosinophilic Asthma: A Positive Feedback Mechanism That Promotes Th2 Immune Response via Filaggrin Deficiency

  2021cites this paper
• Molecular mechanisms of oxidative stress in asthma.

  2021cites this paper
• Asthma

  2021cites this paper
• Selective pharmaceutical inhibition of PARP14 mitigates allergen-induced IgE and mucus overproduction in a mouse model of pulmonary allergic response

  2021cites this paper
• The art of suicidal molecular seduction for targeting drug resistance.

  2020cites this paper
• Clinical characteristics and biomarkers analysis of asthma inflammatory phenotypes.

  2020cites this paper
• Application of novel nanotechnologies in asthma

  2020cites this paper
• Application value of fractional exhaled nitric oxide and myeloperoxidase in phenotypic recognition of severe asthma

  2020cites this paper
• Japanese guidelines for adult asthma 2020.

  2020cites this paper
• An in vitro study to explore the modulation of eosinophil effector function in human allergic peripheral blood eosinophils using enzymatically extracted salmonid oil

  2020cites this paper
• How do biologicals and other novel therapies effect clinically used biomarkers in severe asthma?

  2020cites this paper
• Granulocyte-targeted therapies for airway diseases

  2020cites this paper
• Experimental Methods for Evaluating Pharmacodynamic Effects of Drugs for the Pulmonary System

  2020cites this paper
• Protocol for the Wessex AsThma CoHort of difficult asthma (WATCH): a pragmatic real-life longitudinal study of difficult asthma in the clinic

  2019cites this paper
• The regulatory role of semaphorin 3E in allergic asthma.

  2019cites this paper
• Cannabidiol reduces airway inflammation and fibrosis in experimental allergic asthma

  2019cites this paper
• Precision medicine for the discovery of treatable mechanisms in severe asthma

  2019cites this paper
• Pneumococcal pep27 mutant immunization suppresses allergic asthma in mice.

  2019cites this paper
• Molecular phenotypes of severe asthma

  2019cites this paper
• [ASTHMA PREVENTION AND MANAGEMENT GUIDELINE 2018 (SECTIONS FOR ADULTS): FOCUSING ON THE TREATMENT OF SEVERE ASTHMA].

  2019cites this paper
• Practical Considerations in Management of Non-eosinophilic Asthma

  2019cites this paper
• Role of Metabolic Reprogramming in Pulmonary Innate Immunity and Its Impact on Lung Diseases

  2019cites this paper
• Precision medicine in asthma: linking phenotypes to targeted treatments

  2018cites this paper
• Chinese expert consensus on diagnosis and management of severe asthma.

  2018cites this paper
• Chronic obstructive pulmonary disease phenotypes using cluster analysis of electronic medical records

  2018cites this paper
• Biomarkers for severe allergic asthma in children: could they be useful to guide disease control and use of omalizumab?

  2018cites this paper
• Immunization with an adenovirus-vectored TB vaccine containing Ag85A-Mtb32 effectively alleviates allergic asthma

  2018cites this paper
• Discovery and Validation of New Biomarkers for Personalizing Asthma Therapy

  2018cites this paper
• Evidence-Based Assessment of Bronchial Thermoplasty in Asthma: Mechanisms and Outcomes

  2018cites this paper
• Spectrum of T‐lymphocyte activities regulating allergic lung inflammation

  2017cites this paper
• Severe therapy resistant asthma in children: translational approaches to uncover sub-phenotypes

  2017cites this paper
• Mechanisms Mediating Pediatric Severe Asthma and Potential Novel Therapies

  2017cites this paper
• Role of muscarinic antagonists in asthma therapy

  2017cites this paper
• Phenotyping Asthma : Linking Clinical Features to Biomolecular Pathways

  2017cites this paper
• Personalised medicine in asthma: time for action

  2017cites this paper
• Biomarqueurs systémiques associés à l'asthme persistant ou sévère de l'enfant

  2017cites this paper
• Syk Regulates Neutrophilic Airway Hyper-Responsiveness in a Chronic Mouse Model of Allergic Airways Inflammation

  2017cites this paper
• Biomarqueurs associés au contrôle de l’asthme allergique de l’enfant

  2017cites this paper
• Transcriptomic gene signatures associated with persistent airflow limitation in patients with severe asthma

  2017cites this paper
• The fluctuation behavior of heart and respiratory system signals as a quantitative tool for studying long-term environmental exposures and chronic diseases

  2017cites this paper
• The lung microbiome in virus-induced asthma exacerbations

  2017cites this paper
• Therapeutic modality of plasmacytoid dendritic cells in a murine model of Aspergillus fumigatus sensitized and infected asthma

  2017cites this paper
• Galectin-3: an early predictive biomarker of modulation of airway remodeling in patients with severe asthma treated with omalizumab for 36 months

  2017cites this paper
• A Transcriptome‐driven Analysis of Epithelial Brushings and Bronchial Biopsies to Define Asthma Phenotypes in U‐BIOPRED

  2017cites this paper
• Changing Paradigms in the Treatment of Severe Asthma: The Role of Biologic Therapies.

  2017cites this paper
• Reslizumab: Maintenance treatment for eosinophilic asthma inadequately controlled on corticosteroids.

  2016cites this paper
• Asthma bronchiale – Aktuelle Diagnostik und Therapie

  2016cites this paper
• TLR2 ligation induces corticosteroid insensitivity in A549 lung epithelial cells: Anti-inflammatory impact of PP2A activators.

  2016cites this paper
• [Not Available].

  2016cites this paper
• Airway Microbiota in Severe Asthma and Relationship to Asthma Severity and Phenotypes

  2016cites this paper
• Enhancing the Power of Endogenous Protein Phosphatase 2A to Combat Asthmatic Inflammation: Role for MAPKs and Tristetraprolin

  2016influential citation
• Activating protein phosphatase 2A (PP2A) enhances tristetraprolin (TTP) anti-inflammatory function in A549 lung epithelial cells.

  2016cites this paper
• The safety of monoclonal antibodies in asthma

  2016cites this paper
• Fractional exhaled nitric oxide levels as a predictor of long-term prognoses in patients with mild asthma.

  2016cites this paper
• Role of Eosinophil Granulocytes in Allergic Airway Inflammation Endotypes

  2016cites this paper
• Lebrikizumab in the treatment of asthma

  2016cites this paper
• Can bronchial asthma with an highly prevalent airway (and systemic) vagal tone be considered an independent asthma phenotype? Possible role of anticholinergics.

  2016cites this paper
• ASMA SEVERA EN ADULTOS: ENFOQUE DIAGNÓSTICO Y TRATAMIENTO

  2015cites this paper
• The asthma-COPD overlap syndrome: towards a revised taxonomy of chronic airways diseases?

  2015cites this paper
• Evaluation of Serum Cytokines Levels and the Role of Cannabidiol Treatment in Animal Model of Asthma

  2015cites this paper
• Degeneracy: Demystifying and destigmatizing a core concept in systems biology

  2015cites this paper
• Managing severe asthma in adults: lessons from the ERS/ATS guidelines

  2015cites this paper
• The revised 2014 GINA strategy report: opportunities for change

  2015cites this paper
• Double-stranded RNA evokes exacerbation in a mouse model of corticosteroid refractory asthma.

  2015cites this paper
• Advances in asthma pathophysiology: stepping forward from the Maurizio Vignola experience

  2015cites this paper
• Factors Associated with Emergency Department Visits in Asthma Exacerbation

  2015cites this paper
• Vocal cord dysfunction: asking the right questions

  2015cites this paper
• Asthma is not only an airway disease, but also a vascular disease.

  2015cites this paper
• Clinical phenotypes of asthma should link up with disease mechanisms

  2015cites this paper
• Eosinophilia in asthma: the easy way is not always the best.

  2015cites this paper
• Influence of ethnicity on response to asthma drugs

  2015cites this paper
• [Choice of basic therapy for asthma in real clinical practice].

  2015cites this paper
• Basal protein phosphatase 2A activity restrains cytokine expression: role for MAPKs and tristetraprolin

  2015cites this paper
• Steps to better understand severe asthma in adults

  2015cites this paper
• Astim Tedavisinde Yeni İlaçlar New Drugs in Asthma Treatment

  2015influential citation
• Pharmacogenetic aspects of basic anti- inflammatory therapy of bronchial asthma in school-aged children under the deletion polymorphism of genes Gstt 1 and Gstm 1

  2014cites this paper
• The growing chronic disease burden in Europe: a role for respiratory health professionals?

  2014cites this paper
• Defining Phenotypes in Asthma: A Step Towards Personalized Medicine

  2014cites this paper
• Benralizumab: for asthma, not yet for COPD.

  2014cites this paper
• Omalizumab: Stepping Outside Our Comfort Zone to Broaden the Number of Those Who Can Benefit

  2014cites this paper
• Mutation-targeted personalised medicine for cystic fibrosis.

  2014cites this paper
• Targeted omics and systems medicine: personalising care.

  2014cites this paper